Clovis Oncology (CVLS) IPO Prices at $13, Low End of Range

Clovis Oncology, Inc. (Nasdaq: CLVS) priced its 10,000,000 shares IPO at $13 per share, the low end of the expected $13-$15 range. The size of the offering was raised from 9,300,000 shares. Shares will open today on the Nasdaq under the symbol "CLVS" at approximately 10:40AM.

J. P. Morgan Securities LLC and Credit Suisse Securities (USA) LLC are acting as joint book-running managers for the offering, and Leerink Swann LLC is acting as co-manager for the offering.

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international market.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Credit Suisse High Yield Credit Fund approves 1-for-10 reverse share split
• Alopexx (ALPX) files for 3M share IPO at $10-$12/sh
• Vogenx raises $81.3M in Nasdaq IPO managed by JonesTrading